Replies to post #5823 on InVivo Therapeutics Holdings Corp (NVIVQ)

[BioBull1]

Lots of old price targets and likely will never be hit. Company will need to do a secondary before NSS approval at the rate of enrollment. Will also need a good chunk of cash for the chronic/stem cell trial. Good luck, but I don't see this company valued at half a billion+ ($10 price target assuming 50 million total shares after next raise)